Related Experiment Video
Updated: Jan 17, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Treatment of Refractory Cancer Pain with Methadone
Xiaoting Zeng1, Qianyu Wang2, Weiping Zhang3
1The Third School of Clinical Medicine, Zhejiang Chinese Medicine University, Zhejiang, China.
Abstract:
One-third of cancer patients currently experience cancer-related pain, significantly affecting their quality of life. Since the introduction of the World Health Organization (WHO)'s analgesic ladder, pain management has become increasingly standardised, facilitating more effective treatment strategies. Methadone, classified as a step 3 opioid analgesic on the WHO ladder, is primarily utilised for managing refractory cancer pain. This article explored the advantages and disadvantages of methadone in the context of refractory cancer pain, focusing on its metabolism and pharmacokinetic properties. In conclusion, methadone demonstrates significant advantages in pain relief for cancer patients. With ongoing research into its metabolic mechanisms and dosing strategies, methadone has the potential to become a safer and more widely used opioid in the treatment of refractory cancer pain in the future. Key Words: Methadone, Refractory cancer pain, Metabolism.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Treatment Resistant Cancers
Opioid Analgesics: Morphine and Other Natural Cogeners
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

